The Lariat’s 20-inch chrome-like alloys, shod with Pirelli Scorpion ATR all-terrain light truck tyres (275/60R20) cap off this US pick-up’s bulky style. A lot of its notable design features are ...

An airworthiness directive for ATR turboprops has come into force that requires more regular inspections of the pressure regulator and shut-off valves (PRSOV) that regulate the engine bleed air ...

Ah, the scorpion lollipop, a symbol of the Sonoran Desert. I like them, if only for the campiness of the dark, goth-looking scorpion encased unhappily in a gentle green, pink or blue. That said, ...

While before you could opt for a Vittoria Corsa, a Pirelli P Zero, or a Continental GP4000 you now have an absolute Scrabble board of options like the Goodyear Eagle Supersport R, and now the top ...

DUNWOODY, Ga. — TireHub L.L.C., the national tire distributor co-founded by Goodyear and Bridgestone Americas Inc., will begin distributing Pirelli tires in early 2025. "Pirelli is a complementary ...

Investing.com -- Short seller Scorpion Capital disclosed a short position in TransMedics Group Inc (NASDAQ:TMDX) accusing the organ transplant tech. company of fraudulent practices, including ...

Oscar Piastri laid down a fastest lap time of 1:07 as he ran Pirelli’s new 2026 tyres on a cold and wet Paul Ricard circuit on Wednesday. That, at face value, was considerably quicker than the ...

We look forward to leveraging the great work of the Scorpion team to date, along with Lilly's deep expertise in breast cancer, to further advance STX-478 with speed and focus." Under the terms of ...

Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan Healthcare Conference with a deal to buy Scorpion Therapeutics ...

Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...

Eli Lilly (NYSE:LLY) is in advanced discussions to purchase cancer-focused biotech Scorpion Therapeutics for as much as $2.5 billion. A deal is likely to be reached in the coming days ahead of the ...

Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of ...